Autoantibodies to receptors by an autoantiidiotypic route.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology*; D005260:Female; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008968:Molecular Conformation; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000276:immunology*; D009388:Neostigmine / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000276:immunology*; D011978:Receptors, Nicotinic / Q000276:immunology*; D012737:Sex Factors
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D007130:Immunoglobulin Idiotypes; D000644:Quaternary Ammonium Compounds; D011978:Receptors, Nicotinic; D009388:Neostigmine; C000295:Bis-Q